Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Newsletter Article
|
Ampersand backs Nexcelom BiosciencepeHUB, 2018Copyright Thomson Reuters (Markets) LLC Mar 20, 2018 ;EISSN: 2331-155XFull text available |
|
2 |
Material Type: Newsletter Article
|
CHARLES RIVER COLLABORATES WITH FONDAZIONE TELETHONBiotech Business, 2023, Vol.36 (10)COPYRIGHT 2023 Worldwide Videotex ;Copyright Worldwide Videotex Oct 1, 2023 ;ISSN: 0899-5702Full text available |
|
3 |
Material Type: Newsletter Article
|
Heart Beat: Exercise to strengthen heart and muscles best for diabetesHarvard Heart Letter, 2011COPYRIGHT 2011 Harvard Health Publishing ;COPYRIGHT 2011 All Rights Reserved. ;Copyright Harvard Health Publications May 2011 ;ISSN: 1051-5313 ;EISSN: 1943-510XFull text available |
|
4 |
Material Type: Newsletter Article
|
iNovia Capital leads $8 mln Series A funding of BenchScipeHUB, 2018Copyright Thomson Reuters (Markets) LLC May 2, 2018 ;EISSN: 2331-155XFull text available |
|
5 |
Material Type: Newsletter Article
|
Vittamed scores $10 mln Series ApeHUB, 2015Copyright Thomson Reuters (Markets) LLC Oct 19, 2015 ;EISSN: 2331-155XFull text available |
|
6 |
Material Type: Newsletter Article
|
Oculis nets about $15.6 mlnpeHUB, 2019Copyright Thomson Reuters (Markets) LLC Jan 4, 2019 ;EISSN: 2331-155XFull text available |
|
7 |
Material Type: Newsletter Article
|
Great Point Partners recaps Alliance Biomedical ResearchpeHUB, 2016Copyright Thomson Reuters (Markets) LLC Sep 20, 2016 ;EISSN: 2331-155XFull text available |
|
8 |
Material Type: Newsletter Article
|
Trump seeks to shrink US government in 'America First' budgetSNL Energy Coal Report, 2017Copyright SNL Financial LC Mar 20, 2017 ;EISSN: 1554-5776Full text available |
|
9 |
Material Type: Newsletter Article
|
Luxendo grabs Series A fundspeHUB, 2017Copyright Argosy Group LLC Jan 12, 2017 ;EISSN: 2331-155XFull text available |
|
10 |
Material Type: Newsletter Article
|
Novartis digs deeper into cancer with up to $750 mln Aduro deal -- ReuterspeHUB, 2015Copyright Thomson Reuters (Markets) LLC Mar 30, 2015 ;EISSN: 2331-155XFull text available |
|
11 |
Material Type: Newsletter Article
|
VC-backed Intellia Therapeutics appoints chief financial and strategy officerpeHUB, 2015Copyright Thomson Reuters (Markets) LLC Apr 22, 2015 ;EISSN: 2331-155XFull text available |
|
12 |
Material Type: Newsletter Article
|
Andreessen Horowitz and Thrive Capital fund BenchlingpeHUB, 2015Copyright Thomson Reuters (Markets) LLC Apr 16, 2015 ;EISSN: 2331-155XFull text available |
|
13 |
Material Type: Newsletter Article
|
Venture-backed Zymeworks closes buy of Kairos TherapeuticspeHUB, 2016Copyright Thomson Reuters (Markets) LLC Mar 24, 2016 ;EISSN: 2331-155XFull text available |
|
14 |
Material Type: Newsletter Article
|
Surface Oncology attracts $35 mln Series ApeHUB, 2015Copyright Thomson Reuters (Markets) LLC Jan 8, 2015 ;EISSN: 2331-155XFull text available |
|
15 |
Material Type: Newsletter Article
|
Sentien grabs Series A funds from BIVF and Portage BiotechpeHUB, 2015Copyright Thomson Reuters (Markets) LLC Aug 7, 2015 ;EISSN: 2331-155XFull text available |
|
16 |
Material Type: Newsletter Article
|
Casdin Capital backs Boston startup 908 DevicespeHUB, 2015Copyright Thomson Reuters (Markets) LLC Jul 1, 2015 ;EISSN: 2331-155XFull text available |
|
17 |
Material Type: Newsletter Article
|
IDEAYA Biosciences closes $46 mln Series A, adds to leadership teampeHUB, 2016Copyright Thomson Reuters (Markets) LLC May 4, 2016 ;EISSN: 2331-155XFull text available |
|
18 |
Material Type: Newsletter Article
|
Flare Capital adds two executive partners, hires MIT healthcare econ professorpeHUB, 2016Copyright Thomson Reuters (Markets) LLC May 4, 2016 ;EISSN: 2331-155XFull text available |
|
19 |
Material Type: Newsletter Article
|
C4 Therapeutics raises $73 mlnpeHUB, 2016Copyright Thomson Reuters (Markets) LLC Jan 7, 2016 ;EISSN: 2331-155XFull text available |
|
20 |
Material Type: Newsletter Article
|
VC-backed Rodin Therapeutics adds Singer to boardpeHUB, 2015Copyright Thomson Reuters (Markets) LLC Dec 21, 2015 ;EISSN: 2331-155XFull text available |